AQR Capital Management
CBIO

AQR Capital Management’s Crescent Biopharma CBIO Stock Holding History

AQR Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-976
Closed -$226K – 2269
2021
Q2 		$226K Sell
976
-1,145
-54% -$291K ﹤0.01% 2117
2021
Q1 		$638K Buy
+2,121
New +$760K ﹤0.01% 1744
2020
Q4 		– Sell
-490
Closed -$150K – 2212
2020
Q3 		$150K Buy
490
+7
+1% +$2.68K ﹤0.01% 2101
2020
Q2 		$182K Sell
483
-62
-11% -$17.6K ﹤0.01% 2008
2020
Q1 		$124K Buy
545
+356
+188% +$136K ﹤0.01% 1941
2019
Q4 		$100K Buy
+189
New +$102K ﹤0.01% 2082

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return